Back
BioXcel Therapeutics Vs. Dave Industry Stock Comparison
Sell
32
BTAI
BioXcel Therapeutics
Last Price:
$1.96
Seasonality Move:
-27.39%
Buy
100
DAVE
Dave
Last Price:
$281.24
Seasonality Move:
0.31%
Sell
32
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy, Sell or Hold?
-
The current BioXcel Therapeutics [BTAI] share price is $1.93. The Score for BTAI is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
BTAI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BTAI Stock Price Chart
What is BioXcel Therapeutics's stock price today?
-
The BioXcel Therapeutics share price today is $1.93Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BTAI is experiencing slight selling pressure.
BTAI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 56.97 | Buy |
Chaikin Money Flow: | -37042 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.43 - 1.93) | Buy |
Bollinger Bands (100): | (1.47 - 2.39) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.27 | Buy |
Relative Strength Index (14 RSI): | 71.86 | Buy |
Chaikin Money Flow: | 229455 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (204.25 - 244.21) | Buy |
Bollinger Bands (100): | (77.01 - 197.65) | Buy |
BTAI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.87 | Buy |
20-day SMA: | 1.78 | Buy |
50-day SMA: | 1.64 | Buy |
200-day SMA: | 4.91 | Sell |
8-day EMA: | 1.86 | Buy |
20-day EMA: | 1.77 | Buy |
50-day EMA: | 1.81 | Buy |
200-day EMA: | 9.12 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 245.26 | Buy |
20-day SMA: | 228 | Buy |
50-day SMA: | 183.31 | Buy |
200-day SMA: | 103.44 | Buy |
8-day EMA: | 249.23 | Buy |
20-day EMA: | 229.49 | Buy |
50-day EMA: | 192.22 | Buy |
200-day EMA: | 118.19 | Buy |
BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $6.20 per share, an increase next quarter of $0.92 per share, an increase this year of $19.18 per share, and an increase next year of $1.54 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.35 per share, an increase next quarter of $0.59 per share, an increase this year of $4.51 per share, and an increase next year of $1.44 per share.
BioXcel Therapeutics Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |